These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32668719)

  • 1. A Novel C1-Esterase Inhibitor Oxygenator Coating Prevents FXII Activation in Human Blood.
    Gerling K; Ölschläger S; Avci-Adali M; Neumann B; Schweizer E; Schlensak C; Wendel HP; Stoppelkamp S
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32668719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of adsorption, activation, and inhibition of factor XII on immobilized heparin.
    Sanchez J; Elgue G; Riesenfeld J; Olsson P
    Thromb Res; 1998 Jan; 89(1):41-50. PubMed ID: 9610759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombin III, but not C1 esterase inhibitor reduces inflammatory response in lipopolysaccharide-stimulated human monocytes in an ex-vivo whole blood setting.
    Kellner P; Nestler F; Leimert A; Bucher M; Czeslick E; Sablotzki A; Raspè C
    Cytokine; 2014 Dec; 70(2):173-8. PubMed ID: 25148723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of surface-immobilized heparin on the activation of adsorbed factor XII.
    Elgue G; Sanchez J; Egberg N; Olsson P; Riesenfeld J
    Artif Organs; 1993 Aug; 17(8):721-6. PubMed ID: 8215954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of contact activation on end-point immobilized heparin: the role of antithrombin and the specific antithrombin-binding sequence.
    Sanchez J; Elgue G; Riesenfeld J; Olsson P
    J Biomed Mater Res; 1995 May; 29(5):655-61. PubMed ID: 7622551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of polycarboxybetaine coating and factor XII inhibitor reduces clot formation while preserving normal tissue coagulation during extracorporeal life support.
    Naito N; Ukita R; Wilbs J; Wu K; Lin X; Carleton NM; Roberts K; Jiang S; Heinis C; Cook KE
    Biomaterials; 2021 May; 272():120778. PubMed ID: 33812214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a plasma-derived C1 esterase inhibitor on hemostatic activation, clot formation, and thrombin generation.
    Levy JH; Szlam F; Gelone S
    Blood Coagul Fibrinolysis; 2014 Dec; 25(8):883-9. PubMed ID: 25222191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A monoclonal antibody raised against human beta-factor XIIa which also recognizes alpha-factor XIIa but not factor XII or complexes of factor XIIa with C1 esterase inhibitor.
    Esnouf MP; Burgess AI; Dodds AW; Sarphie AF; Miller GJ
    Thromb Haemost; 2000 Jun; 83(6):874-81. PubMed ID: 10896241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of heparin on the inactivation rate of human activated factor XII by antithrombin III.
    Pixley RA; Schapira M; Colman RW
    Blood; 1985 Jul; 66(1):198-203. PubMed ID: 3873967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oversulfated chondroitin sulfate inhibits the complement classical pathway by potentiating C1 inhibitor.
    Zhou ZH; Rajabi M; Chen T; Karnaukhova E; Kozlowski S
    PLoS One; 2012; 7(10):e47296. PubMed ID: 23077587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1-esterase inhibitor treatment: preclinical safety aspects on the potential prothrombotic risk.
    Schürmann D; Herzog E; Raquet E; Nolte MW; May F; Müller-Cohrs J; Björkqvist J; Dickneite G; Pragst I
    Thromb Haemost; 2014 Nov; 112(5):960-71. PubMed ID: 25103795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Complement and Contact System Activation via C1 Inhibitor Potentiation and Factor XIIa Activity Modulation by Sulfated Glycans - Structure-Activity Relationships.
    Schoenfeld AK; Lahrsen E; Alban S
    PLoS One; 2016; 11(10):e0165493. PubMed ID: 27783665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP; Joseph K
    Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tackling the Root Cause of Surface-Induced Coagulation: Inhibition of FXII Activation to Mitigate Coagulation Propagation and Prevent Clotting.
    Witzdam L; Vosberg B; Große-Berkenbusch K; Stoppelkamp S; Wendel HP; Rodriguez-Emmenegger C
    Macromol Biosci; 2024 Feb; 24(2):e2300321. PubMed ID: 37742317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation.
    Wendel HP; Ziemer G
    Eur J Cardiothorac Surg; 1999 Sep; 16(3):342-50. PubMed ID: 10554855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of activated Factor XII to endothelial cells affects its inactivation by the C1-esterase inhibitor.
    Schousboe I
    Eur J Biochem; 2003 Jan; 270(1):111-8. PubMed ID: 12492481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insight into the effects of heparinoids on complement inhibition by C1-inhibitor.
    Poppelaars F; Damman J; de Vrij EL; Burgerhof JG; Saye J; Daha MR; Leuvenink HG; Uknis ME; Seelen MA
    Clin Exp Immunol; 2016 Jun; 184(3):378-88. PubMed ID: 26874675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: Implication for a role in hereditary angioedema.
    Madsen DE; Sidelmann JJ; Biltoft D; Gram J; Hansen S
    Biochim Biophys Acta; 2015 Jun; 1850(6):1336-42. PubMed ID: 25800206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma-derived human C1-esterase inhibitor does not prevent mechanical ventilation-induced pulmonary complement activation in a rat model of Streptococcus pneumoniae pneumonia.
    de Beer FM; Aslami H; Hoeksma J; van Mierlo G; Wouters D; Zeerleder S; Roelofs JJ; Juffermans NP; Schultz MJ; Lagrand WK
    Cell Biochem Biophys; 2014 Nov; 70(2):795-803. PubMed ID: 24760631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of biopassive and bioactive surface-coatings on the hemocompatibility of membrane oxygenators.
    Zimmermann AK; Weber N; Aebert H; Ziemer G; Wendel HP
    J Biomed Mater Res B Appl Biomater; 2007 Feb; 80(2):433-9. PubMed ID: 16850460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.